BGB-16673
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for BGB-16673, covering 2025-11-21 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 3]